ACOR - Acorda Therapeutics EPS beats by $0.05 beats on revenue November, 04 2019 04:02 PM Acorda Therapeutics Inc. Acorda Therapeutics (NASDAQ:ACOR): Q3 Non-GAAP EPS of -$0.46 beats by $0.05; GAAP EPS of -$5.55 misses by $4.79.More news on: Acorda Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...